Vitrolife & Igenomix USA, Part of Vitrolife Group

Biotechnology Research • Doral, Florida, United States • 51-100 Employees

Company overview

Headquarters	7955 NW 12th St. Suite 415, Miami, FL 33126, US
Phone number	+13055014948
Website	vitrolifegroup.com
NAICS	541714
Founded	1994
Employees	51-100

Key Contacts at Vitrolife & Igenomix USA, Part of Vitrolife Group

Javier Cagigas Benlloch

Tax & Legal Director Usa, Canada & Latam

Refik Kayali

Laboratory Director Us & Canada

Cengiz Cinnioglu

Laboratory Director

Vitrolife & Igenomix USA, Part of Vitrolife Group Email Formats

Vitrolife & Igenomix USA, Part of Vitrolife Group uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@igenomix.com), used 71.9% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@igenomix.com	71.9%
{first initial}.{last name}	j.doe@igenomix.com	28.1%

About Vitrolife & Igenomix USA, Part of Vitrolife Group

The Vitrolife Group is a world-leading global provider of medical devices and genetic testing testing solutions. Dedicated to the reproductive-health market since 1994, we have grown by focusing on product development, groundbreaking research, consistent quality control and acquisitions of innovative companies in the industry. In 2021, Vitrolife acquired Igenomix, a leader in reproductive genetic testing services primarily for IVF clinics. Together we are now the Vitrolife Group, a global leader in reproductive health focused on supporting our customers and patients worldwide to improve treatment outcomes – always with sustainability in mind. Based on science and advanced research capabilities, our aim is to deliver products and services for the entire reproductive-health journey, providing consistent performance and guaranteed quality. Currently, we are approximately 1,100 people worldwide headquartered in Gothenburg, Sweden. Our products and services are available in more than 125 countries, through our own presence in more than 25 countries and a vast network of distributors for the rest of the world. We are on a mission to be the leading valued solution provider in reproductive health and to support customers with successful treatment outcomes.

Vitrolife & Igenomix USA, Part of Vitrolife Group revenue & valuation

Annual revenue	$5,389,965
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$17,300,000
Total funding	No funding

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Manager

Director

Employees by Department

Vitrolife & Igenomix USA, Part of Vitrolife Group has 37 employees across 7 departments.

Departments

Number of employees

Funding Data

Vitrolife & Igenomix USA, Part of Vitrolife Group has never raised funding before.

Frequently asked questions

Vitrolife & Igenomix USA, Part of Vitrolife Group is located in Doral, Florida, US.

You can reach Vitrolife & Igenomix USA, Part of Vitrolife Group at +13055014948.

Vitrolife & Igenomix USA, Part of Vitrolife Group was founded in 1994, making it 32 years old. The company has established itself as a significant player in its industry over this time.

Vitrolife & Igenomix USA, Part of Vitrolife Group has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.